Teleflex | TFX - Ebitda


Teleflex reported $-328.81M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 19.86M 2.06M Dec/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Orthofix International USD 27.88M 2.77M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 389.7M 22.5M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025